The Gabelli Healthcare & Wellness Trust (NYSE:GRX) Shares Shorted: Short Interest Down 52.0% in October

The Gabelli Healthcare & Wellness Trust (NYSE:GRX) was the target of a large drop in short interest in October. As of October 30th, there was short interest totaling 13,460 shares, a drop of 52.0% from the October 15th total of 28,056 shares. Based on an average daily volume of 15,170 shares, the short-interest ratio is presently 0.9 days.

The Gabelli Healthcare & Wellness Trust Trading Down 0.1%

Shares of NYSE:GRX traded down $0.01 during midday trading on Friday, reaching $10.41. 9,782 shares of the company’s stock traded hands, compared to its average volume of 25,481. The Gabelli Healthcare & Wellness Trust has a one year low of $8.80 and a one year high of $10.64. The stock has a 50 day moving average of $9.90 and a 200 day moving average of $9.57.

The Gabelli Healthcare & Wellness Trust Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, December 18th. Investors of record on Friday, December 11th will be issued a $0.20 dividend. This represents a $0.80 annualized dividend and a yield of 7.7%. The ex-dividend date is Friday, December 11th. This is a positive change from The Gabelli Healthcare & Wellness Trust’s previous quarterly dividend of $0.17.

Insider Activity at The Gabelli Healthcare & Wellness Trust

In other The Gabelli Healthcare & Wellness Trust news, major shareholder Saba Capital Management, L.P. bought 8,916 shares of The Gabelli Healthcare & Wellness Trust stock in a transaction on Thursday, November 5th. The stock was acquired at an average price of $10.44 per share, with a total value of $93,083.04. Following the acquisition, the insider owned 2,195,738 shares in the company, valued at approximately $22,923,504.72. This trade represents a 0.41% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Over the last three months, insiders acquired 76,134 shares of company stock valued at $761,708.

Hedge Funds Weigh In On The Gabelli Healthcare & Wellness Trust

A number of hedge funds have recently bought and sold shares of the business. Aviance Capital Partners LLC boosted its stake in shares of The Gabelli Healthcare & Wellness Trust by 0.8% in the third quarter. Aviance Capital Partners LLC now owns 172,847 shares of the investment management company’s stock worth $1,644,000 after acquiring an additional 1,405 shares during the period. International Assets Investment Management LLC grew its position in shares of The Gabelli Healthcare & Wellness Trust by 23.7% during the third quarter. International Assets Investment Management LLC now owns 13,000 shares of the investment management company’s stock worth $124,000 after purchasing an additional 2,492 shares in the last quarter. Uhlmann Price Securities LLC raised its stake in The Gabelli Healthcare & Wellness Trust by 4.6% during the 3rd quarter. Uhlmann Price Securities LLC now owns 81,269 shares of the investment management company’s stock valued at $773,000 after purchasing an additional 3,569 shares during the period. Fifth Third Bancorp bought a new stake in The Gabelli Healthcare & Wellness Trust during the 1st quarter valued at approximately $33,000. Finally, Gamco Investors INC. ET AL raised its stake in The Gabelli Healthcare & Wellness Trust by 1.1% during the 1st quarter. Gamco Investors INC. ET AL now owns 346,026 shares of the investment management company’s stock valued at $3,132,000 after purchasing an additional 3,800 shares during the period.

The Gabelli Healthcare & Wellness Trust Company Profile

The Gabelli Healthcare & Wellness Trust (NYSE: GRX) is a closed-end management investment company focused on long-term growth of capital. Rather than operating healthcare facilities or selling healthcare products directly, the trust invests in the securities of companies involved in healthcare and wellness. Its portfolio may include companies across areas such as pharmaceuticals, biotechnology, medical devices, healthcare services, diagnostics, consumer health, fitness and other wellness-related industries.